No black box warning on record for Orphengesic Forte

As of the latest FDA labeling reviewed, Orphengesic Forte (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Orphengesic Forte medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Reye’s Syndrome may develop in individuals who have chicken pox, influenza, or flu symptoms. Some studies suggest possible association between the development of Reye’s Syndrome and the use of medicines containing salicylate or aspirin. Orphengesic Forte Tablets (Orphenadrine Citrate, Aspirin and Caffeine Tablets 50 mg/ 770 mg/ 60 mg) contain aspirin and therefore are not recommended for

No black box warning on record for Orphengesic Forte

Other warnings & precautions

WARNINGS Reye’s Syndrome may develop in individuals who have chicken pox, influenza, or flu symptoms. Some studies suggest possible association between the development of Reye’s Syndrome and the use of medicines containing salicylate or aspirin. Orphengesic Forte Tablets (Orphenadrine Citrate, Aspirin and Caffeine Tablets 50 mg/ 770 mg/ 60 mg) contain aspirin and therefore are not recommended for

Orphengesic Forte Black Box Warning

No black box warning on record for Orphengesic Forte

Other warnings & precautions

Orphengesic Forte Black Box Warning

No black box warning on record for Orphengesic Forte

Other warnings & precautions